Experimental Oncology
SJR0.261
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.261 | Q4 | 38.4% | |
| 2024 | — | — | 0.241 | Q4 | 38.0% | |
| 2023 | — | — | 0.250 | Q4 | 42.9% | |
| 2022 | — | — | 0.250 | Q4 | 44.9% | |
| 2021 | — | — | 0.272 | Q4 | 48.4% | |
| 2020 | — | — | 0.281 | Q4 | 48.1% | |
| 2019 | — | — | 0.276 | Q3 | 49.7% | |
| 2018 | — | — | 0.366 | Q3 | 56.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
1812-9269
region
Eastern Europe
coverage
1984-2025